This House resolution supports the idea that people in the United States should not pay more for the same prescription drugs than people in other countries. It also supports aligning U.S. drug prices with prices in other developed nations, expanding Medicare drug price negotiation, and promoting competition in the drug market.
The resolution states the House’s support for these approaches. It does not itself set drug prices or require a specific change to drug coverage.
No publicly available information.
The resolution says that U.S. drug prices and per-person spending are higher than in comparison countries. It cites survey findings about people not filling prescriptions, choosing over-the-counter alternatives, or changing how they take medicine because of cost. It supports access to affordable, high-quality prescription drugs.
No publicly available information.